They also ran an exploration program with a new Compound which they saw a good reduction in cholesterol
in the first 14 days. They are looking to potentially have it as a backup or 2nd generation compound.
Also the TBI program with the Walter Reid Army Institute, who is the D.O.D research group.
Studies to be reported this year.
- Forums
- ASX - By Stock
- Ann: Nyrada Announces US Patent Grant for PCSK9 Inhibitor
They also ran an exploration program with a new Compound which...
Featured News
Add NYR (ASX) to my watchlist
|
|||||
Last
6.1¢ |
Change
0.002(3.39%) |
Mkt cap ! $10.93M |
Open | High | Low | Value | Volume |
6.0¢ | 6.1¢ | 5.9¢ | $30.56K | 511.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 85425 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.1¢ | 159534 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 85425 | 0.057 |
1 | 30545 | 0.055 |
2 | 45000 | 0.050 |
1 | 250020 | 0.040 |
1 | 29440 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.061 | 159534 | 2 |
0.065 | 49180 | 1 |
0.067 | 50000 | 1 |
0.068 | 60000 | 1 |
0.069 | 33333 | 1 |
Last trade - 15.01pm 22/08/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online